Merry Life Biomedical's TML-6 Enters Global Phase 2 Alzheimer's Study
The Taiwan-developed oral therapy will be tested at 20 sites across Taiwan, Sweden and the United States in about 210…
Research
Peer-reviewed work, and what it means outside the lab.
69 stories Page 4 of 6
Rainmaker raises $100m Series B to expand cloud seeding research
The El Segundo company says the round will fund a larger atmospheric research team and lower the cost of producing new…
Abbisko reports preliminary Phase II results for achondroplasia drug
Seven children aged 6 to 12 in the lowest dose cohort recorded a mean 2.4 cm/year rise in annualized height velocity…
Insilico Medicine releases open AI toolkit for aging research
A Cell cover study from the company introduces an open benchmark, a family of compact language models and an agentic…
Eight-year ADAURA update reports long-term osimertinib survival benefit
An exploratory landmark analysis of the Phase III ADAURA trial reports eight-year overall survival rates for adjuvant…
Kelun-Biotech says phase III results for HER2 ADC published in Journal of Clinical Oncology
The Chinese company said late-stage trial data for trastuzumab botidotin in HER2-positive advanced breast cancer have…
NUS Researchers Report PEMF Therapy Cleared Breast Tumours in Preclinical Models
A study in Smart Medicine describes how pulsed electromagnetic fields converted tumour-associated macrophages into…
Phase III trial reports survival gain for anti-B7-H3 antibody-drug conjugate in relapsed small-cell lung cancer
The TAISHAN-302 study found tambotatug pelitecan improved overall survival, progression-free survival and response…
MRI surveillance alone improves cognitive outcomes in SCLC trial, researchers say
A phase III trial found that brain MRI surveillance without prophylactic cranial irradiation reduced the risk of…
Sacituzumab Govitecan Plus Pembrolizumab Fails to Show Statistically Significant PFS Benefit in PD-L1-High NSCLC
Primary results from the Phase 3 EVOKE-03/KEYNOTE-D46 trial showed numerically longer progression-free survival with…
Phase III ARTEMIS-008: Ris-Rez cuts death risk 54% in relapsed SCLC
The B7-H3-directed antibody-drug conjugate outperformed topotecan on overall survival, progression-free survival and…
Nine years of one solar chemistry, and a module that reaches 760 watts
Dinto Solar, spun out of a state research institute, says its heterojunction modules now reach 760 W as it works toward…